VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 140 filers reported holding VIKING THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $718,548 | -62.4% | 43,156 | -78.8% | 0.16% | -64.6% |
| Q4 2022 | $1,909,666 | +51.6% | 203,156 | -56.1% | 0.46% | +83.7% |
| Q3 2022 | $1,260,000 | -47.8% | 463,156 | -44.6% | 0.25% | -43.0% |
| Q2 2022 | $2,414,000 | +51.3% | 835,275 | +56.9% | 0.44% | +109.5% |
| Q1 2022 | $1,596,000 | -30.7% | 532,429 | +6.3% | 0.21% | -38.8% |
| Q4 2021 | $2,303,000 | -26.7% | 500,642 | 0.0% | 0.34% | +55.2% |
| Q3 2021 | $3,144,000 | 0.0% | 500,642 | -4.6% | 0.22% | -13.0% |
| Q2 2021 | $3,144,000 | -31.4% | 524,754 | -27.6% | 0.25% | +64.9% |
| Q1 2021 | $4,584,000 | +57200.0% | 724,754 | +62432.7% | 0.15% | +15300.0% |
| Q2 2020 | $8,000 | -98.6% | 1,159 | -99.1% | 0.00% | -97.7% |
| Q1 2020 | $590,000 | -82.7% | 126,159 | -70.4% | 0.04% | -92.1% |
| Q4 2019 | $3,418,000 | – | 426,159 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |